Skip to main content
Clinical Trials/ACTRN12610000063011
ACTRN12610000063011
Completed
Phase 4

A prospective randomized controlled trial to compare postoperative liver functions, cytokines and complications between isoflurane inhaled and propofol intravenous anesthesia in cirrhotic patients undergoing hepatectomy for hepatic carcinoma

Shanghai Rising-Star Program (No 08QA14007)0 sites60 target enrollmentJanuary 19, 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Shanghai Rising-Star Program (No 08QA14007)
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 19, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shanghai Rising-Star Program (No 08QA14007)

Eligibility Criteria

Inclusion Criteria

  • 1\. Elective liver resection
  • 2\. American Society of Anesthesiologists (ASA) physical status II\-III patients
  • 3\. Primary liver cancer patients who had history of hepatitis B related cirrhosis
  • 4\. undergoing combined general and epidural anesthesia

Exclusion Criteria

  • 1\.Contradictions of epidural puncture including coagulate disorder (prothrombin time (PT) longer than 15 sec or/and blood platelets count less than 10,000\)
  • 2\.Tumor size too large or small ( longitude of tumor was beyond 3\-8 cm) or estimated blood loss was large than 1000 cc.
  • 3\.Individuals in whom the regional block failed and surgery was performed under general anesthesia alone were also withdrawn from the study.
  • 4\.Indivduals fail to be performed Pringer’s maneuver due to technologic problem.

Outcomes

Primary Outcomes

Not specified

Similar Trials